ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 232 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,822 | -72.2% | 1,479 | -68.0% | 0.01% | -78.1% |
| Q2 2023 | $110,769 | +20.3% | 4,625 | -20.0% | 0.03% | +3.2% |
| Q4 2022 | $92,081 | +18.1% | 5,784 | +4.2% | 0.03% | -35.4% |
| Q2 2022 | $78,000 | -74.3% | 5,550 | -55.7% | 0.05% | -68.6% |
| Q1 2022 | $304,000 | +12.2% | 12,517 | +8.0% | 0.15% | +21.4% |
| Q4 2021 | $271,000 | +71.5% | 11,589 | +21.8% | 0.13% | +23.5% |
| Q3 2021 | $158,000 | -33.9% | 9,518 | -2.8% | 0.10% | -32.0% |
| Q2 2021 | $239,000 | +455.8% | 9,793 | +492.1% | 0.15% | +111.3% |
| Q1 2021 | $43,000 | – | 1,654 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |